Translate Bio Inc.

The momentum for this stock is not very good. Translate Bio Inc. has good growth characteristics. Translate Bio Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Translate Bio Inc..

Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on deve...

News

Telesis Bio to delist its securities from Nasdaq

Seeking Alpha - Healthcare Telesis Bio to delist its securities from Nasdaq...\n more…

Telesis Bio to delist shares from Nasdaq

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market

Globe Newswire SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO) ( Telesis or the Company ), a leading provider of RNA and DNA solutions enabling researchers to accelerate...\n more…

Telesis Bio (NASDAQ:TBIO) Stock Price Up 3.8%

Ticker Report Shares of Telesis Bio, Inc. (NASDAQ:TBIO - Get Free Report) rose 3.8% during trading on Wednesday . The stock traded as high as $3.65 and last traded at $3.55. Approximately 38,792 shares traded...\n more…

Telesis Bio Board Shake-Up: New Chair, Committee Restructuring

TipRanks Financial Blog An announcement from Telesis Bio (TBIO) is now available. Five members of Telesis Bio Inc.'s Board of Directors, including Franklin R. Witney and Todd R. Nelson, re...\n more…

TBIO Stock Earnings: Telesis Bio Misses EPS, Misses Revenue for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nTBIO stock results show that Telesis Bio missed analyst estimates for earnings per share and missed on revenue for the second quarter of...\n more…